Delisting riskPopularity #5,164
IN8bio (INAB)
Develops gamma-delta T-cell therapies and engagers for cancer and autoimmune disease.
$1.21
After hours+0.08 (+7.08%)
At close$1.13(+6.60%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 44 days
EPS estimate
−$0.34
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.20−$2.10−$1.24−$0.85−$0.26−$0.26−$0.25Pending
Estimate−$0.07−$1.80−$1.50−$1.20−$0.18−$0.59−$0.34−$0.34
Surprise−1,614.3%−16.7%+17.3%+29.2%−44.4%+55.9%+27.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———$5.8M$16.0M———
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.22 | — | — |
| Sep 2027 | −$0.35 | — | — |
| Jun 2027 | −$0.34 | — | — |
| Mar 2027 | −$0.33 | — | — |
| Dec 2026 | −$0.35 | — | — |
| Nov 2026 | −$0.34 | — | — |
| Aug 2026 | −$0.34 | −$0.25 | +27.3% |
| May 2026 | −$0.59 | −$0.26 | +55.9% |
| Mar 2026 | −$0.18 | −$0.26 | −44.4% |
| Nov 2025 | −$1.20 | −$0.85 | +29.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.22 | — | — | $3.3M | — | — | — |
| Sep 2027 | −$0.35 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.34 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.33 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.35 | — | — | $0 | — | — | — |
| Nov 5, 2026 | −$0.34 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.34 | −$0.25 | +27.3% | — | — | — | +0.9% |
| May 7, 2026 | −$0.59 | −$0.26 | +55.9% | — | — | — | +1.3% |
| Mar 12, 2026 | −$0.18 | −$0.26 | −44.4% | $16.0M | — | — | −4.0% |
| Nov 6, 2025 | −$1.20 | −$0.85 | +29.2% | $5.8M | — | — | +1.8% |
| Aug 7, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 10, 2021 | |||||||
| Jul 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |